Cervical Cancer Vaccine

Cervical Cancer Vaccine - most related articles:

- Gardasil vaccine to prevent cervical cancer in India - 10.4
- HPV vaccine Cervarix in UK's immunisation programme - 7.8
- GSK's cervical cancer vaccine Cervarix got WHO prequalification - 7.7
- Gardasil HPV vaccine reduces abnormal pap test results - 7.7
- Gardasil is eligible for UN immunization programs - 7.6
- Cervical cancer screening might safely be delayed after HPV vaccine - 7.2
- IUDs may lower cervical cancer risk - 6.8
- HPV vaccine reduces subsequent cervical disease in women - 6.8
- Regular pap tests boost chances of cure from cervical cancer - 6.6
- Cervical cancer screening to 50000 women in India - 6.5

Cervical Cancer Vaccine articles

HPV vaccine reduces subsequent cervical disease in women
HPV vaccination does not reduce progression to cervical disease in women, but vaccinated women had less frequent subsequent cervical disease. Women who are diagnosed with pre-cancerous cervical conditions after receiving the HPV vaccine can still benefit from a considerably reduced risk of reoccurring disease.

GSK's cervical cancer vaccine Cervarix got WHO prequalification
The World Health Organization (WHO) has awarded prequalification to Cervarix, GlaxoSmithKline's cervical cancer vaccine. GlaxoSmithKline pharmaceutical company applied for WHO prequalification of Cervarix 2 years ago.

New gene silencing way to turn off cervical cancer genes
Researchers at The University of Queensland have developed a way to deliver drugs which can specifically shut down cancer-causing genes in tumour cells while sparing normal healthy tissues.

Benefit to women not enough to sway men to get HPV vaccine
Informing men that a new vaccine to prevent human papillomavirus (HPV) would also help protect their female partners against developing cervical cancer from the sexually transmitted infection did not increase their interest in getting the vaccine, according to a new Florida State University study.

Gardasil is eligible for UN immunization programs
GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant], Merck's cervical cancer vaccine, has been awarded World Health Organization (WHO) pre-qualification. GARDASIL is the first cervical cancer vaccine to receive WHO pre-qualification.

Gardasil efficacious against HPV 16 infection
In a study of an extended follow up of 290 women naïve to HPV type 16, the HPV 16 component of GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant] was efficacious against HPV 16 infection for an average of 8.5 years after administration.

Cervical cancer screening might safely be delayed after HPV vaccine
DNA from human papilloma virus type 16 (HPV16) and HPV type 18 (HPV18) were found in the majority of invasive cervical cancers in New Mexico in the 1980s and 1990s, according to a population-based study published in the March 24 online issue of the Journal of the National Cancer Institute.

Gardasil HPV vaccine prevented genital lesions in men
GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], the cervical cancer vaccine from Merck & Co., Inc., prevented 90 percent of external genital lesions caused by human papillomavirus (HPV) types 6, 11, 16 and 18 in a pivotal Phase III study in men aged 16 to 26.

HPV vaccine Cervarix in UK's immunisation programme
The UK's leading cervical cancer charity, Jo's Trust, has welcomed the UK's Department of Health's announcement that the HPV vaccine, Cervarix will be used in the national immunisation programme for 12/13 year olds starting in September, 2008.

Gardasil HPV vaccine reduces abnormal pap test results
A significant drop in abnormal Pap test results happened after girls and women were given Gardasil vaccine to prevent cervical cancer, according to a researcher at the University of Alabama at Birmingham (UAB).

10 Cervical Cancer Vaccine articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
2.64